Arii S,Yamaoka Y,Futagawa S,et al.Results of surgicaland nonsurgical treatment for small-sized hepatocel-lular carcinomas:a retrospective and nationwide survey in Japan[J].Hepatology,2000,32(6):1224-1229.
[2]
汤钊猷.复发与转移―原发性肝癌研究的一个重点[J].中华肝胆外科杂志,1999,5(1):325.
[3]
Lee JG,Kang CM,Park JS,et al.The actual five year survival rate of hepatocellular carcinoma patients after curative resection[J].Yonsei Med,2006,47(1):105.
[4]
Jonathan D Schwartz,Myron Schwartz,John Mandeli.Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma:review of the randomised clinical trials[J].The lancet Oncology,2002,3(10):593-603.
[5]
Jin-qing Li,Ya-qi Zhang.Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy[J].Journal of Cancer Research And Clinical Oncology,1995,121(6):364.
Lu X,Zhao H,Yang H,et al.A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy[J].J Surg Oncol,2009,100:488-493.
[8]
Eguchi S,Matsumoto S,Hamasak K,et al.Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection[J].J Hepatobiliary Pancreat Surg,2008,15:627-633.
